K.Vita: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy

This prospective open-label feasibility study aimed to evaluate acceptability, tolerability and compliance with dietary intervention with K.Vita, a medical food containing a unique ratio of decanoic acid to octanoic acid, in individuals with drug-resistant epilepsy. Adults and children aged 3–18 yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoeler, Natasha E, Orford, Michael, Vivekananda, Umesh, Simpson, Zoe, Van de Bor, Baheerathi, Smith, Hannah, Balestrini, Simona, Rutherford, Tricia, Brennan, Erika, McKenna, James, Lambert, Bridget, Barker, Tom, Jackson, Richard, Williams, Robin S B, Sisodiya, Sanjay M, Eaton, Simon, Heales, Simon J R, Cross, J Helen, Walker, Matthew C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557697/
https://www.ncbi.nlm.nih.gov/pubmed/34729477
http://dx.doi.org/10.1093/braincomms/fcab160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557697/
https://www.ncbi.nlm.nih.gov/pubmed/34729477
http://dx.doi.org/10.1093/braincomms/fcab160

Ejemplares similares